Guided Therapeutics (GTHP) Interest Coverage Ratio (2016 - 2025)
Guided Therapeutics (GTHP) has disclosed Interest Coverage Ratio for 16 consecutive years, with 3.86 as the latest value for Q4 2025.
- Quarterly Interest Coverage Ratio rose 3.17% to 3.86 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.84 through Dec 2025, up 30.55% year-over-year, with the annual reading at 3.84 for FY2025, 30.52% up from the prior year.
- Interest Coverage Ratio hit 3.86 in Q4 2025 for Guided Therapeutics, down from 3.76 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.82 in Q3 2021 to a low of 21.81 in Q2 2023.
- Historically, Interest Coverage Ratio has averaged 6.52 across 5 years, with a median of 5.03 in 2025.
- Biggest five-year swings in Interest Coverage Ratio: crashed 863.18% in 2022 and later skyrocketed 59.96% in 2024.
- Year by year, Interest Coverage Ratio stood at 4.35 in 2021, then tumbled by 211.33% to 13.54 in 2022, then soared by 50.26% to 6.74 in 2023, then surged by 40.84% to 3.99 in 2024, then grew by 3.17% to 3.86 in 2025.
- Business Quant data shows Interest Coverage Ratio for GTHP at 3.86 in Q4 2025, 3.76 in Q3 2025, and 4.86 in Q2 2025.